Stem Cell Therapy for Knee Osteoarthritis: New Research and Nonsurgical Options

November 18, 2026

University of Miami researchers are studying artery-delivered stem cells for knee osteoarthritis. Learn what this investigational treatment could mean for the future of regenerative medicine.

Knee osteoarthritis affects millions of people, causing chronic pain, stiffness, swelling, and difficulty with everyday activities. For many patients, the condition gradually limits their ability to walk comfortably, exercise, climb stairs, or participate in the activities they enjoy.

Although treatments such as physical therapy, medications, and injections can help manage symptoms, they do not work equally well for everyone. Patients who continue to experience pain despite conservative treatment may face difficult decisions about what to try next, including whether to consider knee replacement surgery.

New research from the University of Miami Miller School of Medicine is exploring a different approach to treating knee osteoarthritis: delivering stem cells through the arteries that supply the knee rather than injecting them directly into the joint.

The investigational approach represents an emerging area of regenerative medicine research, combining cell-based therapies with minimally invasive, image-guided techniques. While much remains to be learned, the study highlights the ongoing effort to develop more targeted treatment strategies for people living with osteoarthritis.

New University of Miami Clinical Trial Explores Stem Cells for Knee Osteoarthritis

In October 2026, researchers at the University of Miami Miller School of Medicine announced that the U.S. Food and Drug Administration had authorized a clinical trial investigating artery-delivered stem cells for knee osteoarthritis.

The study will evaluate the safety and feasibility of delivering mesenchymal stem/stromal cells (MSCs) through small arteries supplying the knee.

The planned trial will focus on patients with mild to moderate knee osteoarthritis who continue to experience symptoms despite conventional nonsurgical treatments.

Researchers also intend to explore potential changes in several clinical outcomes, including:

  • Knee pain and discomfort
  • Joint stiffness
  • Mobility and physical function
  • Quality of life
  • Imaging findings related to the knee

The initial study is designed primarily to determine whether the procedure can be performed safely and feasibly. Additional research will be needed to establish whether this approach provides meaningful and lasting improvements for patients.

Importantly, the study has received authorization to proceed, but patient enrollment had not yet begun at the time of the announcement. The treatment remains investigational and is not an established standard of care for knee osteoarthritis.

How Is Artery-Delivered Stem Cell Therapy Different From a Traditional Injection?

One of the most interesting aspects of the University of Miami study is its approach to delivering stem cells.

Many previous studies investigating stem cell-based treatments for osteoarthritis have involved injecting cells directly into the knee joint. The new research will examine whether delivering cells through the arteries supplying the knee offers another potential strategy.

The cells being studied are mesenchymal stem/stromal cells derived from donated umbilical cord tissue and manufactured under FDA-regulated conditions at the university.

Rather than placing the cells directly into the joint space, physicians will use minimally invasive, image-guided techniques to deliver them through small arteries supplying tissues around the knee.

Why Target the Blood Vessels Supplying the Knee?

Osteoarthritis is more complex than the gradual wearing away of cartilage. Inflammation within and around the joint can contribute to pain, swelling, stiffness, and impaired function.

The researchers’ approach builds on work involving a procedure called genicular artery embolization (GAE), which targets abnormal blood vessels associated with chronic inflammation around the knee.

By combining concepts from vascular intervention and regenerative medicine, investigators hope to explore whether targeted arterial delivery of stem cells could influence the inflammatory environment around an osteoarthritic joint.

Mesenchymal stem/stromal cells are being studied for their potential immunomodulatory and tissue-supporting effects. However, it remains uncertain whether delivering these cells through the arteries will improve knee osteoarthritis symptoms or affect disease progression.

The clinical trial is an important early step toward answering those questions.

Understanding the Role of Stem Cells in Regenerative Medicine

Stem cell research has attracted considerable attention because of its potential to expand the way physicians approach certain musculoskeletal conditions.

Mesenchymal stem/stromal cells are of particular interest because researchers are investigating their interactions with the immune system and their ability to release biological signals that may influence inflammation and tissue repair.

However, the term stem cell therapy encompasses a range of different approaches. Treatments may differ in their cellular source, manufacturing process, preparation, delivery method, and intended biological effects.

These differences matter when interpreting research findings.

Evidence supporting one cell product or delivery method cannot automatically be applied to another. Likewise, promising laboratory findings do not necessarily translate into meaningful improvements in patients.

For knee osteoarthritis, researchers continue to investigate whether cell-based approaches can improve pain and function, how long any benefits might last, which patients could benefit, and what risks may be associated with treatment.

The University of Miami trial adds another question to this research: Does the route of delivery influence the potential effects of a cell-based therapy?

Answering that question will require carefully designed clinical studies and long-term follow-up.

Knee Osteoarthritis Treatment: What Are the Nonsurgical Options Today?

While researchers investigate new approaches to regenerative medicine, patients with knee osteoarthritis have several established treatment options that may help manage symptoms and preserve function.

The most appropriate approach depends on factors such as the severity of arthritis, the patient’s activity level, medical history, previous treatments, and individual goals.

1. Physical Therapy and Exercise

Appropriately tailored exercise can help strengthen the muscles supporting the knee, improve joint mobility, and maintain physical function.

A physical therapist can develop a program that accounts for the patient’s symptoms and limitations while helping them remain active.

2. Activity Modification and Weight Management

Adjusting activities that aggravate knee pain and incorporating lower-impact exercise may help reduce discomfort.

For patients who are overweight, weight management can also reduce the mechanical load placed on the knee and may improve osteoarthritis symptoms.

3. Medication and Injection-Based Treatments

Depending on the patient’s circumstances, physicians may recommend topical or oral medications to manage pain and inflammation.

Certain injections may also be considered. These include corticosteroid injections for selected patients and platelet-rich plasma (PRP), which is being investigated and used in clinical practice for knee osteoarthritis.

The evidence for injection-based treatments varies, and potential benefits, limitations, and risks should be discussed with a qualified clinician.

4. Regenerative Medicine Approaches

Regenerative medicine encompasses a range of approaches being studied for their potential to influence biological processes associated with pain, inflammation, and tissue healing.

PRP uses a concentration of platelets derived from a patient’s own blood. Researchers are investigating its potential role in managing symptoms associated with several musculoskeletal conditions, including knee osteoarthritis.

Other cell-based therapies are also being studied, including the approaches described in the University of Miami research.

These treatments are not interchangeable, and the evidence supporting each approach differs. Patients should understand what a particular treatment involves, what the available research shows, and whether its use is supported for their individual condition.

5. Minimally Invasive Procedures and Surgical Consultation

For some patients, procedures targeting specific sources of knee pain may be appropriate. Others with advanced osteoarthritis and substantial functional limitations may benefit from an orthopedic evaluation to discuss knee replacement.

The goal is not to avoid surgery at all costs. It is to identify an appropriate treatment plan based on the patient’s condition, symptoms, and goals.

What Does This Research Mean for Patients Considering Regenerative Medicine?

The University of Miami study illustrates an important principle in the development of regenerative medicine: researchers are investigating not only which biological therapies might be useful, but also how those therapies could be delivered to the tissues they are intended to affect.

Nevertheless, it is important to distinguish an innovative research approach from a proven treatment.

The FDA’s authorization for the clinical trial allows investigators to study the proposed procedure under the applicable regulatory framework. It does not establish that the treatment is effective or that it is approved for routine treatment of knee osteoarthritis.

Patients should also be cautious of broad claims that stem cells can regenerate damaged cartilage, reverse arthritis, or eliminate the need for joint replacement. Such outcomes should not be assumed without convincing clinical evidence.

Before considering any regenerative medicine treatment, patients should ask:

  • What specific treatment is being proposed, and what does it involve?
  • What clinical evidence supports its use for my condition?
  • What benefits can reasonably be expected?
  • What are the potential risks and limitations?
  • Is the treatment part of an appropriately regulated clinical trial or established clinical practice?
  • What other nonsurgical and surgical options should I consider?

A thoughtful evaluation can help patients distinguish evidence-based care from treatments promoted on the basis of preliminary findings or unsupported claims.

How Sampson Regen Approaches Nonsurgical Musculoskeletal Care

At Sampson Regen, the focus is on evaluating musculoskeletal conditions and considering individualized treatment strategies that may help patients manage pain and maintain function without immediately resorting to surgery.

Treatment decisions should account for the underlying condition, the patient’s symptoms, previous treatment history, and overall goals.

Depending on the diagnosis and clinical circumstances, nonsurgical approaches may include physical rehabilitation, image-guided procedures like platelet-rich plasma (PRP), bone marrow concentrate. These may be combined with other appropriate treatment modalities such as Shockwave, Robotic Laser, and EmSculptNeo, which may help improve muscle function that can support the knee.

Research involving stem cells and other biological therapies is an important part of the broader evolution of regenerative medicine. However, emerging research must be evaluated carefully, and an investigational treatment should not be presented as an established option simply because early findings are promising.

For patients with knee osteoarthritis, a comprehensive evaluation can help clarify the extent of the condition, identify potential contributors to pain, and determine which treatment options are appropriate.

No single treatment is right for everyone, and results can vary from patient to patient.

The Future of Knee Osteoarthritis Treatment

The University of Miami’s investigation into artery-delivered stem cells represents a novel direction in the study of knee osteoarthritis.

By combining cell-based research with minimally invasive vascular techniques, investigators hope to learn whether a different delivery strategy could eventually offer benefits to patients who continue to struggle despite conventional nonsurgical care.

The immediate priority is establishing the safety and feasibility of the approach. Further clinical evidence will be necessary to determine whether it improves pain, mobility, or quality of life and how it compares with existing treatment options.

For patients living with knee osteoarthritis, the research reinforces the importance of continued scientific investigation alongside individualized clinical care.

Although no single approach works for every patient, advances in our understanding of inflammation, joint biology, and regenerative medicine may help inform future treatment strategies.

If you are experiencing persistent knee pain, an evaluation with a qualified medical professional can help you understand your diagnosis and explore appropriate nonsurgical and surgical options.

At Sampson Regen, we believe informed treatment decisions begin with understanding the available evidence, setting realistic expectations, and developing a plan tailored to each patient’s needs.

Source: University of Miami Miller School of Medicine, FDA Authorizes Novel Clinical Trial Exploring Artery-Delivered Stem Cells for Knee Osteoarthritis, October 19, 2026.

This field is for validation purposes and should be left unchanged.
Name(Required)